Skip to main content

Table 1 Demographic characteristics of newborns enrolled

From: Nasal high flow therapy in very low birth weight infants with mild respiratory distress syndrome: a single center experience

Demographics characteristics Results
Mothers
 Age, m (DS) 33.7 (±5,5)
 Primigravida, n (%) 36 (56%)
 Antenatal glucocorticoids (either complete or incomplete), n (%)a 54 (84%)
 Cesarean Section, n (%) 56 (87%)
 Multiple birth, n (%) 24 (37%)
 High risk pregnancy, n (%)b 32 (50%)
Newborns
 Gestational age (GA), weeks, m (DS) 29.4 (±2,1)
 Distribution per week of gestational age (GA
  26 weeks GA, n (%) 3 (4.5%)
  27 weeks GA, n (%) 10 (16%)
  28 weeks GA, n (%) 13 (20%)
  29 weeks GA, n (%) 7 (11%)
  30 weeks GA, n (%) 9 (14%)
  31 weeks GA, n (%) 8(12.5%)
  32 weeks GA, n (%) 10 (16%)
  33 weeks GA, n (%) 3 (4.5%)
  34 weeks GA, n (%) 0 (0%)
  35 weeks GA, n (%) 1 (1.5%)
 Birth weight, g, m (DS) 1166 (±241)
 VLBW, n (%) 49 (76%)
 ELBW, n (%) 15 (23%)
 SGA, n (%) 18 (28%)
 Males, n (%) 32 (50%)
 Apgar score at 5 min, m (DS) 8.7 (±0,3)
 Neonatal resuscitation, n (%)c 55 (85%)
 Silverman score at enrollment, m (DS) 5.7 (±1,0)
 FiO2 at enrollment, m (DS) 26.3 (±4,8)
 PCO2 at enrollment, m (DS) 46.9 (±7,6)
 pH at enrollment, m (DS) 7.2 (±0,06)
  1. aAntenatal glucocorticoids are medication given to pregnant women expecting a preterm birth that reduce newborn mortality and RDS
  2. bHigh risk pregnancy namely clinically diagnosed chorioamnionitis, prolonged premature rupture of membranes greater than 18 h, preeclampsia, and placental abruption
  3. cOxygen Therapy and Positive pressure ventilation with face mask